Live Rate
| Open | |
|---|---|
| High | |
| Low | |
| Prev. Close | |
| Lower circuit | |
| Upper circuit | |
| 52w High | |
| 52w Low | |
| P/E Ratio |
KRM Ayurveda Listing Price
| Exchange | Listing Price | Gain/Loss | % |
|---|---|---|---|
| NSE | ₹172.10 | +₹37.10 | +27.48% |
KRM Ayurveda Subscription
Last updated on 23-Jan-2026 17:01:03
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 1032000 | 65338000 | 63.31 |
| HNIs | 780000 | 105585000 | 135.37 |
| bHNI | 520000 | 86595000 | 166.53 |
| sHNI | 260000 | 18990000 | 73.04 |
| Individual | 1812000 | 98222000 | 54.21 |
| Total | 3624000 | 269145000 | 74.27 |
Application-Wise Breakup  | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 173 | 10615 | 61.36 |
| HNIs (3-10L) | 87 | 6022 | 69.22 |
| Individual | 906 | 49111 | 54.21 |
| Subscription Demand (in ₹ crore) | |||
|---|---|---|---|
| Category | Offered | Demand | Times |
| QIB | 13.93 | 882.06 | 63.31 |
| FII | - | 131.37 | - |
| FI | - | 0 | - |
| IC | - | 14.05 | - |
| MF | - | 0.09 | - |
| OTH | - | 736.55 | - |
| HNIs | 10.53 | 1417.65 | 134.63 |
| bHNI | 7.02 | 1169.03 | 166.53 |
| sHNI | 3.51 | 256.37 | 73.04 |
| Individual | 24.46 | 1326 | 54.21 |
| Total | 48.92 | 3625.71 | 74.11 |
| QIB Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹11.5 | @8% ₹13.1 | @9% ₹14.8 | @10% ₹16.4 | @11% ₹18 | @12% ₹19.7 |
KRM Ayurveda Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| bHNI | 8 | 8000 | 1080000 | 173 |
KRM Ayurveda Reservation
| Category | Shares Offered | % |
|---|---|---|
| Anchor | 1542000 | 26.86% |
| QIB | 1032000 | 17.98% |
| HNI | 780000 | 13.59% |
| INDIVIDUAL | 1812000 | 31.57% |
| Market Maker | 574000 | 10% |
| Total | 5740000 | 100% |
KRM Ayurveda About
IPO Details
| Total Issue Size | 57,40,000 shares (aggregating up to ₹77.49 Cr) |
| Fresh Issue | 57,40,000 shares (aggregating up to ₹77.49 Cr) |
| Face Value | ₹10/- Per Share |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,55,20,800 shares |
| Share Holding Post Issue | 2,12,60,800 shares |
| Reserved for Market Maker | 5,74,000 shares (aggregating up to ₹7.29 Cr) |
| Market Maker | Mansi Share & Stock Broking Pvt.Ltd. |
Key Performance Indicators (KPI)
| KPI | Sep-25 | Mar-25 | Mar-24 |
|---|---|---|---|
| ROE | 21.84% | 67.86% | 33.88% |
| ROCE | 21.84% | 43.33% | 20.80% |
| EPS (BASIC) | 5.24 | 8.06 | 2.27 |
| P/E Pre IPO | 17.32 | ||
| P/E Post IPO | 23.73 |
Company Financial (In ₹Crore)
| Period Ended | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Assets | 78.12 | 66.79 | 43.91 | 39.48 |
| Total Income | 48.65 | 76.95 | 67.57 | 89.38 |
| Profit After Tax | 8.14 | 12.1 | 3.41 | 7.6 |
| EBITDA | 12.83 | 19.11 | 7.34 | 11.03 |
| NET Worth | 36.13 | 23.88 | 11.78 | 8.37 |
| Reserves and Surplus | 20.61 | 23.73 | 11.63 | 8.22 |
| Total Borrowing | 25.07 | 31.2 | 23.18 | 19.87 |
Peer Comparison (Valuation)
| Company | P/E (x) | CMP*(₹) | Face value (₹) |
|---|---|---|---|
| KRM Ayurveda Limited | 17.32 | 135.00 | 10.00 |
| Jeena Sikho Lifecare Ltd | 76.58 | 678.50 | 2.00 |
| Vaidya Sane Ayurved Laboratories Ltd | 93.20 | 286.00 | 10.00 |
Peer Comparison (Financial Performance)
| Company | NAV/Share (₹) | RoNW (%) | EPS (Basic) (₹) |
|---|---|---|---|
| KRM Ayurveda Limited | 25.64 | 27.13 | 5.24 |
| Jeena Sikho Lifecare Ltd | 142.24 | 31.28 | 8.86 |
| Vaidya Sane Ayurved Laboratories Ltd | 59.85 | 5.12 | 3.07 |
About Company
Incorporated on 3 September 2019, KRM Ayurveda Ltd operates a network of Ayurvedic hospitals and clinics across India and has expanded overseas through telemedicine consultations and product sales.
Currently runs 6 hospitals and 5 clinics at multiple locations, providing integrated Ayurvedic healthcare services.
Manufactures Ayurvedic medicines, herbal & botanical remedies, supplements, and wellness / skincare-related products.
Service offerings include hospital-based treatments, clinic consultations, teleconsultation services, and KRM-branded Ayurvedic products.
As of August 31, 2025, the company employs 429 staff across medical, operational, and administrative departments.
IPO proceeds will be utilised for telemedicine facility development (₹13.67 cr), CRM & IT infrastructure (₹1.42 cr), human resources (₹5.44 cr), loan repayment (₹12.50 cr), working capital (₹18.00 cr), and general corporate purposes.
Strength
Qualified Ayurvedic professionals – Skilled physicians and certified therapists ensure consistent treatment quality.
GMP-certified centralized manufacturing – Ensures purity, safety, and efficacy of Ayurvedic medicines.
Trusted brand with repeat clientele – Strong patient loyalty supports recurring revenue and brand equity.
Weakness
Non-ownership of premises – Hospitals and offices are on leased properties; forced relocation could disrupt operations.
Employee attrition risk – Higher attrition among frontline and technical staff may impact service quality and scalability.
Geographical revenue concentration – Majority revenue derived from top two states exposes the company to regional risks.
KRM Ayurveda Latest Announcements
| Date | Subject | Attachment Text |
|---|
KRM Ayurveda Financial Results
KRM Ayurveda Lead Manager(s)
KRM Ayurveda Address
Address
A-16
G T Karnal road
North West Delhi, New Delhi, 110033
+91- 9289101700
E-mail: compliance@krmayurveda.com
Website: https://www.krmayurvedaindia.com/